HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19.
Front Immunol. 2022 May 3;13:841716. doi: 10.3389/fimmu.2022.841716. eCollection 2022.
Front Immunol. 2022.
PMID: 35592335
Free PMC article.